Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
06 Setembro 2023 - 8:30AM
Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a
company pioneering a single-molecule protein analysis platform,
today announced the company will be participating in the following
investor conferences:
- Morgan Stanley 21st Annual Global Healthcare Conference in New
York, NYManagement is scheduled to participate in a fireside chat
on Wednesday, September 13th at 7:50 a.m. Pacific Time / 10:50 a.m.
Eastern Time.
- Gilmartin Group Emerging Growth Company Showcase,
VirtualManagement is scheduled to present on Thursday, September
21st at 7:30 a.m. Pacific Time / 10:30 a.m. Eastern Time.
Interested parties may access live and archived webcasts of the
presentations on the “Investors” section of the company website at:
www.nautilus.bio.
About Nautilus Biotechnology, Inc.With its
corporate headquarters in Seattle, Washington and its research and
development headquarters in San Carlos, California, Nautilus is a
development stage life sciences company working to create a
platform technology for quantifying and unlocking the complexity of
the proteome. Nautilus’ mission is to transform the field of
proteomics by democratizing access to the proteome and enabling
fundamental advancements across human health and medicine. To learn
more about Nautilus, visit www.nautilus.bio.
Media Contactpress@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
Nautilus Biotechnology (NASDAQ:NAUT)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Nautilus Biotechnology (NASDAQ:NAUT)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024